Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition
Article in BMC Cancer (December 2022)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in BMC Cancer (December 2022)
Book chapter (October 2022)
Article in Frontiers in Oncology (September 2022)